The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 7,595,723 | 571,107 | SH | SOLE | 571,107 | 0 | 0 | ||
| ABIVAX SA | SPONSORED ADS | 00370M103 | 46,534,392 | 349,200 | SH | Call | SOLE | 349,200 | 0 | 0 | |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 33,634,824 | 252,400 | SH | Put | SOLE | 252,400 | 0 | 0 | |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 21,598,038 | 163,644 | SH | SOLE | 163,644 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 1,674,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| ALUMIS INC | COM | 022307102 | 5,628,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| AMGEN INC | COM | 031162100 | 3,621,200 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | |
| AMGEN INC | COM | 031162100 | 214,645 | 102,701 | SH | SOLE | 102,701 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 2,016,772 | 353,200 | SH | Call | SOLE | 353,200 | 0 | 0 | |
| ANNEXON INC | COM | 03589W102 | 157,116 | 27,516 | SH | SOLE | 27,516 | 0 | 0 | ||
| APREA THERAPEUTICS INC | COM NEW | 03836J201 | 36,029 | 44,907 | SH | SOLE | 44,907 | 0 | 0 | ||
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 892,736 | 214,600 | SH | Call | SOLE | 214,600 | 0 | 0 | |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 6,900,062 | 223,810 | SH | SOLE | 223,810 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 3,822,920 | 124,000 | SH | Call | SOLE | 124,000 | 0 | 0 | |
| ARDELYX INC | COM | 039697107 | 1,545,428 | 303,025 | SH | SOLE | 303,025 | 0 | 0 | ||
| ARS PHARMACEUTICALS INC | COM | 82835W108 | 38,929 | 4,860 | SH | SOLE | 4,860 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 7,460 | 12,500 | SH | Put | SOLE | 12,500 | 0 | 0 | |
| AYTU BIOPHARMA INC | COM | 054754858 | 319,374 | 148,546 | SH | SOLE | 148,546 | 0 | 0 | ||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 1,961,950 | 462,724 | SH | SOLE | 462,724 | 0 | 0 | ||
| BIOAGE LABS INC | COM | 09077V100 | 3,586,646 | 146,334 | SH | SOLE | 146,334 | 0 | 0 | ||
| BIOAGE LABS INC | COM | 09077V100 | 4,904,451 | 200,100 | SH | Call | SOLE | 200,100 | 0 | 0 | |
| BIOGEN INC | COM | 09062X103 | 12,963,600 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | |
| BIOHAVEN LTD | COM | G1110E107 | 4,716,960 | 317,000 | SH | Call | SOLE | 317,000 | 0 | 0 | |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 17,901,048 | 312,846 | SH | SOLE | 312,846 | 0 | 0 | ||
| BIONTECH SE | SPONSORED ADS | 09075V102 | 9,305,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| BRIDGEBIO PHARMA INC | NOTE 1.750% 3/0 | 10806XAJ1 | 18,620,000 | 250,000 | PRN | SOLE | 250,000 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 19,049,172 | 330,600 | SH | Put | SOLE | 330,600 | 0 | 0 | |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 34,572,000 | 600,000 | SH | Call | SOLE | 600,000 | 0 | 0 | |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 12,868,352 | 534,400 | SH | Put | SOLE | 534,400 | 0 | 0 | |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 7,929,544 | 329,300 | SH | Call | SOLE | 329,300 | 0 | 0 | |
| CARTESIAN THERAPEUTICS INC | COM NEW | 816212302 | 907,134 | 87,057 | SH | SOLE | 87,057 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 2,092,400 | 20,000 | SH | Call | SOLE | 20,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 3,200,060 | 86,000 | SH | Put | SOLE | 86,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,893,989 | 50,900 | SH | Call | SOLE | 50,900 | 0 | 0 | |
| CELLECTAR BIOSCIENCES INC | COM NEW | 15117F880 | 384,588 | 138,341 | SH | SOLE | 138,341 | 0 | 0 | ||
| CG ONCOLOGY INC | COM | 156944100 | 518,665 | 7,300 | SH | Call | SOLE | 7,300 | 0 | 0 | |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 19,104,797 | 493,664 | SH | SOLE | 493,664 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | 468,824 | 196,985 | SH | SOLE | 196,985 | 0 | 0 | ||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 1,962,424 | 119,733 | SH | SOLE | 119,733 | 0 | 0 | ||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 2,825,856 | 301,264 | SH | SOLE | 301,264 | 0 | 0 | ||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 5,945,044 | 633,800 | SH | Call | SOLE | 633,800 | 0 | 0 | |
| CORCEPT THERAPEUTICS INC | COM | 218352102 | 17,937,785 | 206,300 | SH | Call | SOLE | 206,300 | 0 | 0 | |
| CORMEDIX INC | COM | 21900C308 | 1,314,875 | 167,500 | SH | Put | SOLE | 167,500 | 0 | 0 | |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 4,404,476 | 294,811 | SH | SOLE | 294,811 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 1,992,996 | 133,400 | SH | Call | SOLE | 133,400 | 0 | 0 | |
| CUE BIOPHARMA INC | COM | 22978P205 | 1,526,526 | 48,369 | SH | SOLE | 48,369 | 0 | 0 | ||
| CUE BIOPHARMA INC | COM | 22978P205 | 6 | 6 | SH | Call | SOLE | 6 | 0 | 0 | |
| CYBIN INC | COM NEW | 23256X407 | 661,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| CYBIN INC | COM NEW | 23256X407 | 1,322,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 2,555,700 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 726,815 | 15,451 | SH | SOLE | 15,451 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 11,060,055 | 272,214 | SH | SOLE | 272,214 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 1,296,000 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
| ELI LILLY & CO | COM | 532457108 | 11,994,300 | 10,000 | SH | Put | SOLE | 10,000 | 0 | 0 | |
| ELICIO THERAPEUTICS INC | COM | 28657F103 | 391,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| ELICIO THERAPEUTICS INC | COM | 28657F103 | 438,311 | 112,100 | SH | Call | SOLE | 112,100 | 0 | 0 | |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 507,500 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| ENTERA BIO LTD | SHS | M40527109 | 41,170 | 23,260 | SH | SOLE | 23,260 | 0 | 0 | ||
| EQUILLIUM INC | COM | 29446K106 | 1,280,902 | 400,282 | SH | SOLE | 400,282 | 0 | 0 | ||
| ERASCA INC | COM | 29479A108 | 1,832 | 100 | SH | Call | SOLE | 100 | 0 | 0 | |
| EVOLUS INC | COM | 30052C107 | 1,388,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| EYEPOINT INC | COM NEW | 30233G209 | 1,520,090 | 106,300 | SH | Call | SOLE | 106,300 | 0 | 0 | |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | 326,511 | 66,908 | SH | SOLE | 66,908 | 0 | 0 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 978,118 | 26,864 | SH | SOLE | 26,864 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 195,783 | 458,723 | SH | SOLE | 458,723 | 0 | 0 | ||
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | 6,715,579 | 193,700 | SH | Put | SOLE | 193,700 | 0 | 0 | |
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | 6,934,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 8,091,900 | 254,863 | SH | SOLE | 254,863 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 11,948,144 | 105,400 | SH | Put | SOLE | 105,400 | 0 | 0 | |
| INDIVIOR PHARMACEUTICALS INC | COM | 45579U109 | 2,770,017 | 67,512 | SH | SOLE | 67,512 | 0 | 0 | ||
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | 302,720 | 275,200 | SH | Call | SOLE | 275,200 | 0 | 0 | |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 3,384,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| INVENTIVA SA | ADS | 46124U107 | 2,725,718 | 740,786 | SH | SOLE | 740,786 | 0 | 0 | ||
| JADE BIOSCIENCES INC | COM NEW | 008064206 | 3,174 | 1,046 | SH | Put | SOLE | 1,046 | 0 | 0 | |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | 102,479 | 9,021 | SH | SOLE | 9,021 | 0 | 0 | ||
| JOHNSON & JOHNSON | COM | 478160104 | 5,587,340 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | 79,771 | 3,621 | SH | SOLE | 3,621 | 0 | 0 | ||
| KODIAK SCIENCES INC | COM | 50015M109 | 7,663,432 | 196,700 | SH | Call | SOLE | 196,700 | 0 | 0 | |
| KODIAK SCIENCES INC | COM | 50015M109 | 5,723,224 | 146,900 | SH | Put | SOLE | 146,900 | 0 | 0 | |
| KODIAK SCIENCES INC | COM | 50015M109 | 8,497,838 | 218,117 | SH | SOLE | 218,117 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 17,166,099 | 149,700 | SH | Call | SOLE | 149,700 | 0 | 0 | |
| LAKELAND INDS INC | COM | 511795106 | 150,815 | 14,108 | SH | SOLE | 14,108 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 447,243 | 146,637 | SH | SOLE | 146,637 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 1,729,742 | 374,403 | SH | SOLE | 374,403 | 0 | 0 | ||
| MANNKIND CORP | COM NEW | 56400P706 | 68,173 | 16,003 | SH | SOLE | 16,003 | 0 | 0 | ||
| MEIRAGTX HLDGS PLC | COM | G59665102 | 6,755 | 500 | SH | Call | SOLE | 500 | 0 | 0 | |
| MEIRAGTX HLDGS PLC | COM | G59665102 | 113,052 | 8,368 | SH | SOLE | 8,368 | 0 | 0 | ||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 1,520,242 | 56,347 | SH | SOLE | 56,347 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 7,003,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | 150,922 | 1,630 | SH | SOLE | 1,630 | 0 | 0 | ||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 4,116,420 | 170,100 | SH | Call | SOLE | 170,100 | 0 | 0 | |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 1,897,062 | 78,391 | SH | SOLE | 78,391 | 0 | 0 | ||
| NEXTCURE INC | COM NEW | 65343E207 | 12,387 | 7,742 | SH | SOLE | 7,742 | 0 | 0 | ||
| NOVARTIS AG | SPONSORED ADR | 66987V109 | 7,836,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| NOVARTIS AG | SPONSORED ADR | 66987V109 | 15,672,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| NOVO-NORDISK A S | ADR | 670100205 | 2,679,846 | 55,900 | SH | Put | SOLE | 55,900 | 0 | 0 | |
| NOVO-NORDISK A S | ADR | 670100205 | 4,809,442 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 2,948,536 | 121,539 | SH | SOLE | 121,539 | 0 | 0 | ||
| OCUGEN INC | COM | 67577C105 | 306,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 2,645,631 | 27,799 | SH | SOLE | 27,799 | 0 | 0 | ||
| PELTHOS THERAPEUTICS INC | COM SHS | 171126204 | 700,085 | 24,773 | SH | SOLE | 24,773 | 0 | 0 | ||
| PEPGEN INC | COM | 713317105 | 671,911 | 373,284 | SH | SOLE | 373,284 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 1,013,920 | 29,321 | SH | SOLE | 29,321 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 1,409,958 | 129,950 | SH | SOLE | 129,950 | 0 | 0 | ||
| PRECIGEN INC | COM | 74017N105 | 771,170 | 135,293 | SH | SOLE | 135,293 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,722,390 | 926,016 | SH | SOLE | 926,016 | 0 | 0 | ||
| PROTHENA CORP PLC | SHS | G72800108 | 1,463,429 | 149,482 | SH | SOLE | 149,482 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 1,168,482 | 388,200 | SH | Call | SOLE | 388,200 | 0 | 0 | |
| RELAY THERAPEUTICS INC | COM | 75943R102 | 4,315,967 | 230,677 | SH | SOLE | 230,677 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 2,500,660 | 361,367 | SH | SOLE | 361,367 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 7,708,041 | 696,300 | SH | Call | SOLE | 696,300 | 0 | 0 | |
| REPLIMUNE GROUP INC | COM | 76029N106 | 5,562,675 | 502,500 | SH | Put | SOLE | 502,500 | 0 | 0 | |
| REVOLUTION MEDICINES INC | COM | 76155X100 | 26,072,747 | 139,218 | SH | SOLE | 139,218 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM | 766559702 | 892,562 | 22,816 | SH | SOLE | 22,816 | 0 | 0 | ||
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 5,607,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| SELLAS LIFE SCIENCES GROUP I | COM NEW | 81642T209 | 5,904,000 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
| SELLAS LIFE SCIENCES GROUP I | COM NEW | 81642T209 | 1,476,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| SEPTERNA INC | COM | 81734D104 | 1,999,353 | 59,700 | SH | Put | SOLE | 59,700 | 0 | 0 | |
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | 1,620,000 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,331,700 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | 2,914,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | 874,200 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | 12,533,114 | 860,200 | SH | Call | SOLE | 860,200 | 0 | 0 | |
| TALPHERA INC | COM NEW | 00444T209 | 158,170 | 153,563 | SH | SOLE | 153,563 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 3,559,035 | 522,619 | SH | SOLE | 522,619 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 4,466,850 | 307,000 | SH | Call | SOLE | 307,000 | 0 | 0 | |
| TG THERAPEUTICS INC | COM | 88322Q108 | 4,158,958 | 75,700 | SH | Call | SOLE | 75,700 | 0 | 0 | |
| TVARDI THERAPEUTICS INC | COM | 140755307 | 31,553 | 16,607 | SH | SOLE | 16,607 | 0 | 0 | ||
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | 3,717,294 | 792,600 | SH | Call | SOLE | 792,600 | 0 | 0 | |
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | 1,424,240 | 303,676 | SH | SOLE | 303,676 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 13,771,940 | 299,000 | SH | Put | SOLE | 299,000 | 0 | 0 | |
| UNIQURE NV | SHS | N90064101 | 10,842,524 | 235,400 | SH | Call | SOLE | 235,400 | 0 | 0 | |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 28,711,030 | 52,989 | SH | SOLE | 52,989 | 0 | 0 | ||
| UPSTREAM BIO INC | COM | 91678A107 | 132,124 | 19,093 | SH | SOLE | 19,093 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 262,642 | 7,137 | SH | SOLE | 7,137 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 2,842,557 | 48,900 | SH | Put | SOLE | 48,900 | 0 | 0 | |
| VAXCYTE INC | COM | 92243G108 | 2,619,977 | 45,071 | SH | SOLE | 45,071 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 3,086,703 | 53,100 | SH | Call | SOLE | 53,100 | 0 | 0 | |
| VERA THERAPEUTICS INC | CL A | 92337R101 | 2,471,959 | 57,608 | SH | SOLE | 57,608 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 2,145,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| VIKING THERAPEUTICS INC | COM | 92686J106 | 17,234,930 | 441,808 | SH | SOLE | 441,808 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 13,673,005 | 350,500 | SH | Put | SOLE | 350,500 | 0 | 0 | |
| VIKING THERAPEUTICS INC | COM | 92686J106 | 47,623,408 | 1,220,800 | SH | Call | SOLE | 1,220,800 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,837,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 13,040 | 57,700 | SH | Call | SOLE | 57,700 | 0 | 0 | |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 1,447,747 | 413,642 | SH | SOLE | 413,642 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 525,000 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 1,051,348 | 132,746 | SH | SOLE | 132,746 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985Y108 | 3,715,330 | 142,132 | SH | SOLE | 142,132 | 0 | 0 | ||